Stockreport

Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings

Monopar Therapeutics Inc.  (MNPR) 
PDF WILMETTE, Ill., April 16, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovativ [Read more]